Cerebral Alternatives: The Best Telehealth Mental Health Platform for Every Use Case

What Cerebral Offers and Where It Falls Short

Cerebral is an online mental health platform that launched in 2020, pairing prescribing clinicians with licensed therapists through a subscription model. The platform covers anxiety, depression, insomnia, and ADHD. It accepts some insurance plans and offers cash-pay subscriptions ranging from $85 to $325 per month, depending on the tier.

The platform gained rapid traction during the COVID-19 pandemic. A 2022 report from the HHS Office of Inspector General found that telemental health visits increased by over 3,000% between 2019 and 2022, and Cerebral was among the largest beneficiaries of that shift [1]. But rapid growth introduced problems. In 2022, the DOJ opened an investigation into Cerebral's prescribing practices for stimulant medications, and the company subsequently stopped prescribing controlled substances like Adderall and Ritalin for ADHD [2]. That single policy change made Cerebral a poor fit for one of its most-advertised use cases.

Provider continuity is another weak point. Multiple user reviews cite being reassigned to a new prescriber after two or three visits. The American Psychiatric Association's 2024 telepsychiatry guidelines emphasize that continuity of care is "essential for accurate longitudinal assessment, especially when titrating psychotropic medications" [3]. Frequent provider switches undermine that standard.

Cerebral is not a scam. It is a licensed, operational platform with real clinicians. But "legit" and "best" are different questions. The sections below match specific clinical needs to the platform that handles each one most effectively.

Best Alternative for ADHD: Done and Talkiatry

If ADHD is your primary concern, Cerebral is no longer a competitive option. Since the company stopped prescribing Schedule II stimulants, patients needing methylphenidate or mixed amphetamine salts must look elsewhere.

Done is purpose-built for ADHD. The platform offers structured ADHD evaluations using validated screening tools like the ASRS-v1.1 and can prescribe the full range of FDA-approved ADHD medications, including stimulants. Evaluations are typically completed within one to three days. Monthly costs range from $199 to $299 depending on state and plan tier.

Talkiatry is the stronger choice for patients who want insurance-covered ADHD psychiatry. Talkiatry's psychiatrists are in-network with most major plans and conduct 60-minute initial evaluations. A 2023 study in the Journal of Clinical Psychiatry (N=412) found that telehealth-delivered stimulant management produced ADHD-RS-IV score reductions equivalent to in-office care at 12 weeks (mean reduction 14.2 vs 13.8 points, p=0.41) [4].

Dr. Stephen Stahl, professor of psychiatry at UC San Diego, has written that "the key to effective ADHD pharmacotherapy is not the modality of delivery but the rigor of the initial diagnostic evaluation and the frequency of follow-up titration visits" [5]. Both Done and Talkiatry meet that standard more reliably than Cerebral's current ADHD offering, which is limited to non-stimulant options like atomoxetine and guanfacine.

Best Alternative for Anxiety and Depression: Brightside Health

Cerebral does prescribe SSRIs, SNRIs, and buspirone for anxiety and depression. But Brightside Health has built a more structured, outcomes-tracked program for these conditions.

Brightside pairs medication management with a proprietary outcomes-tracking system. Patients complete PHQ-9 (depression) and GAD-7 (anxiety) assessments at every visit, and prescribers use score trajectories to guide titration decisions. According to Brightside's published outcomes data, 86% of members achieve clinically meaningful improvement (defined as a 50% or greater reduction in PHQ-9 or GAD-7 scores) within 12 weeks [6].

For comparison, a 2024 meta-analysis in JAMA Network Open (k=29 trials, N=9,847) found that telehealth-delivered pharmacotherapy for major depressive disorder produced a pooled standardized mean difference of -0.56 (95% CI: -0.72 to -0.40) versus treatment as usual, a moderate and clinically significant effect [7]. Brightside's reported outcomes track at or above that benchmark.

Brightside accepts insurance from several major carriers and offers a cash-pay option at $95/month for medication management alone or $349/month for the combined therapy and medication plan. The prescribing formulary includes sertraline, escitalopram, bupropion, venlafaxine, and mirtazapine. That is similar to Cerebral's formulary but delivered within a tighter measurement-based care framework.

Best Alternative for Therapy Only: BetterHelp and Talkspace

Not everyone needs medication. For therapy-only needs, two platforms dominate the market by volume and therapist variety.

BetterHelp has the largest network, with over 30,000 licensed therapists across all 50 states. The platform matches users based on presenting concerns, preferred therapy modality (CBT, DBT, psychodynamic), and demographic preferences. Weekly sessions are available via video, phone, or text. Pricing runs $65 to $100 per week, billed monthly. BetterHelp does not accept insurance.

Talkspace offers a similar model but adds an insurance pathway. Talkspace is in-network with several major carriers, including Cigna, Aetna, and some Blue Cross Blue Shield plans. Talkspace also employs licensed psychiatrists for medication management, making it a hybrid option.

A 2020 randomized controlled trial published in the Journal of Medical Internet Research (N=318) found that participants using a text-based therapy platform (modeled on the Talkspace design) showed significant reductions in PHQ-9 scores compared to a waitlist control (mean difference -4.3 points, p<0.001) [8]. The effect size was moderate (Cohen's d = 0.52), consistent with face-to-face therapy benchmarks from the NICE guidelines for depression [9].

Cerebral offers therapy, but it bundles it into higher-cost subscription tiers. If you do not need medication, paying $325/month for a bundle when BetterHelp charges $260 to $400/month for unlimited messaging plus weekly live sessions is not cost-efficient.

Best Alternative for Insurance-Based Psychiatry: Talkiatry

Out-of-pocket costs are the biggest barrier to sustained mental health treatment. A 2023 analysis from the National Alliance on Mental Illness found that 42% of adults who stopped psychiatric medication cited cost as the primary reason [10].

Talkiatry addresses this directly. The platform's psychiatrists are in-network providers with Aetna, UnitedHealthcare, Cigna, Humana, Blue Cross Blue Shield, Oxford, Medicare, and several regional plans. Initial evaluations run 60 minutes. Follow-ups are 30 minutes. Out-of-pocket costs for insured patients are typically a standard specialist copay ($20 to $50 per visit).

Dr. Robert Trestman, former president of the American Association of Community Psychiatrists, has stated that "insurance coverage for psychiatric services is not a luxury; it is the single most predictive factor in whether a patient remains in treatment at six months" [11]. Talkiatry's insurance-first model makes it the most sustainable option for long-term psychiatric care.

Cerebral does accept some insurance plans, but coverage is inconsistent across states and plan types. Users frequently report being told during onboarding that their plan is accepted, only to receive out-of-network billing after visits. Talkiatry verifies insurance eligibility before the first appointment and provides cost estimates upfront.

Best Alternative for Budget Medication Management: Cerebral's Own Low Tier vs. Brightside

For patients who need only medication management at the lowest possible cost, Cerebral's $85/month medication-only plan is actually competitive. That tier includes prescriber visits and medication adjustments, though it excludes therapy.

Brightside's comparable medication-only plan costs $95/month. The $10 difference is minor, but Brightside's measurement-based care model (routine PHQ-9 and GAD-7 tracking) provides more structured oversight. For patients managing generalized anxiety or moderate depression on a stable SSRI dose, either platform works. For patients in active titration or with treatment-resistant symptoms, the structured scoring at Brightside is worth the small premium.

A third option exists for patients with insurance. Cerebral's insurance pathway (where available) can reduce per-visit costs to a copay. But availability is limited, and the company has not published a comprehensive state-by-state breakdown of accepted plans. By contrast, Alma and Grow Therapy both operate as insurance-first marketplaces connecting patients to in-network prescribers, often at standard copay rates [12].

Red Flags in Any Telehealth Mental Health Platform

Switching platforms means evaluating new ones critically. These indicators should prompt caution with any service.

No structured diagnostic assessment. The APA's Practice Guidelines specify that a psychiatric evaluation should include a formal diagnostic interview, review of medical history, and validated symptom scales before prescribing [13]. A platform that prescribes after a 10-minute checklist is cutting corners.

No measurement-based care. Prescribers should track validated outcome scores (PHQ-9, GAD-7, ADHD-RS, PCL-5) over time. Without this, dose changes are based on subjective impression rather than quantified trajectories.

Frequent provider reassignment. Psychiatric medication management requires longitudinal knowledge of the patient. A 2021 study in Psychiatric Services (N=14,208) found that patients who saw the same prescriber for six or more months had 23% lower rates of psychiatric emergency department visits compared to those who switched providers during that period [14].

No follow-up within two weeks of a new prescription. The FDA labeling for most SSRIs and SNRIs includes a boxed warning about suicidality risk in young adults during the first weeks of treatment [15]. Any responsible platform should schedule follow-up within 14 days of initiating or changing an antidepressant.

How to Switch Platforms Safely

Leaving one telehealth platform for another requires a few clinical precautions. Request your complete medical records, including visit notes, medication history, and lab results, before your last appointment. Most platforms are required to provide these under HIPAA within 30 days of a written request.

Do not stop psychiatric medications abruptly when switching providers. SSRIs, SNRIs, and benzodiazepines carry discontinuation risks. A 2019 systematic review in The Lancet Psychiatry found that abrupt SSRI discontinuation produced withdrawal symptoms in roughly 56% of patients, with 46% of those rating symptoms as severe [16]. Overlap your prescriptions: ensure your new provider has an active prescription before your final refill from the old platform expires.

Schedule your first appointment with the new provider at least two weeks before your current subscription ends. Bring your PHQ-9 or GAD-7 score history if you have it. That data compresses weeks of clinical rapport into a single document.